Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma

Overview of attention for article published in Blood Cancer Journal, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 24 X users

Readers on

mendeley: 69 Mendeley

So far, Altmetric has seen 29 X posts from 24 X users, with an upper bound of 181,794 followers.

RT @FrancescoMaura4: @lbaughn @DrOlaLandgren @NatureComms @SylvesterCancer Thanks for your kind words! To be honest, I believe that in 2021…

@lbaughn @DrOlaLandgren @NatureComms @SylvesterCancer Thanks for your kind words! To be honest, I believe that in 2021 FISH should be replaced by NGS platforms (e.g. https://t.co/yw8ncNlGEl and https://t.co/A2K2npBvG2). They are far more comprehensive b…

RT @VincentRK: myTYPE assay for detection of recurring genomic abnormalities in myeloma. Blood Cancer Journal #BCJ @malinhultcrantz @DrOlaL…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 25 additional X posts.